Federal grants to Reveragen Biopharma, Inc.
Reveragen Biopharma, Inc. in Rockville, Maryland received $2.9 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Extramural Research Programs in the Neurosciences and Neurological Disorders, with $1.7 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$2.9 million
- Awards3
- Awarded in FY 2025$0
- Largest award$1.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $2.3 million |
| FY 2022 | 1 | $0 |
| FY 2023 | 0 | $0 |
| FY 2024 | 1 | $601,151 |
| FY 2025 | 0 | $0 |
Programs that fund Reveragen Biopharma, Inc.
| Program | Awards | Amount |
|---|---|---|
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 2 | $1.7 million |
| Food and Drug Administration Research | 1 | $1.2 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $2.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Commercialization readiness pilot (CRP) to maximize vamorolone international labeling and sales | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 1, 2021 | $1.7 million |
| Vamorolone trial in becker muscular dystrophy - abstract becker dystrophy is caused by partial loss of function of the dystrophin protein in muscle tissues and some non-muscle cells, with progressive dysfunction of skeletal and cardiac muscle. Mutations of the dmd gene cause both becker dystrophy an | Food and Drug Administration Research | September 20, 2021 | $1.2 million |
| Phase iia study of VBP15 for duchenne muscular dystrophy | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 26, 2022 | $0 |
Questions people ask
How much federal grant money does Reveragen Biopharma, Inc. get?
$2.9 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Reveragen Biopharma, Inc. the most?
The Department of Health and Human Services, with $2.9 million in 3 awards.
What is Reveragen Biopharma, Inc.'s largest federal grant?
$1.7 million under Extramural Research Programs in the Neurosciences and Neurological Disorders, with its first action in the period on September 1, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Reveragen Biopharma, Inc.?
Its largest are Extramural Research Programs in the Neurosciences and Neurological Disorders and Food and Drug Administration Research.
Other grant recipients in Rockville
- X Energy, LLC
- Abt Global LLC
- Westat, Inc.
- The United States Pharmacopeial Convention, Inc.
- Montgomery College
- JBS International, Inc.
- Child Trends, Incorporated
- Sanaria Inc.
Largest federal grant recipients in Maryland · Federal grants in Maryland